Versor Investments’s Idexx Laboratories IDXX Stock Holding History

Versor Investments’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,518	Closed	-$637K	–	810
2025 Q1	$637K	Buy	1,518 +1,018	+204%	+$442K	0.1%	328
2024 Q4	$207K	Sell	500 -2,220	-82%	-$974K	0.04%	683
2024 Q3	$1.37M	Buy	+2,720	New	+$1.32M	0.22%	105
2024 Q2	–	Sell	-808	Closed	-$436K	–	817
2024 Q1	$436K	Buy	+808	New	+$442K	0.09%	372
2019 Q4	–	Sell	-2,100	Closed	-$571K	–	332
2019 Q3	$571K	Buy	2,100 +100	+5%	+$27.8K	0.04%	208
2019 Q2	$551K	Buy	+2,000	New	+$493K	0.04%	208
2018 Q3	–	Sell	-1,300	Closed	-$283K	–	265
2018 Q2	$283K	Buy	+1,300	New	+$268K	0.1%	210
2017 Q4	–	Sell	-1,882	Closed	-$293K	–	262
2017 Q3	$293K	Sell	1,882 -1,195	-39%	-$189K	0.1%	132
2017 Q2	$497K	Buy	3,077 +1,640	+114%	+$266K	0.13%	64
2017 Q1	$222K	Buy	+1,437	New	+$198K	0.09%	88

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Versor Investments's IDXX Position: Q2 2025 in Review

Versor Investments sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 1,518 shares — an estimated $637K sold.

Versor Investments first reported a position in IDXX in Q1 2017 and held it in 10 quarters. The position peaked at $1.37M in Q3 2024. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

Versor Investments reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
Versor Investments sold 1,518 Idexx Laboratories shares in Q2 2025, an estimated $637K.
Versor Investments first reported a position in Idexx Laboratories in Q1 2017 and held it in 10 quarters.
Versor Investments's Idexx Laboratories position peaked at $1.37M in Q3 2024.
1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Versor Investments's 13F filing for Q2 2025, filed 5 Aug 2025.